⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL68459 | 0.81 | — | — | |
| SCHEMBL7037006 | 0.78 | — | — | |
| SCHEMBL11508783 | 0.73 | — | — | |
| SCHEMBL4521389 | 0.72 | — | — | |
| SCHEMBL2537848 | 0.71 | — | — | |
| SCHEMBL31063929 | 0.71 | — | — | |
| SCHEMBL14546289 | 0.71 | — | — | |
| SCHEMBL214487 | 0.71 | — | — | |
| SCHEMBL16508635 | 0.70 | — | — | |
| SCHEMBL29154614 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034810-B2 | Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting | NOVARTIS AG (CH) | 2011-10-11 | — | — | US | disclosed |
| CN-101010290-B | Diimmonium compound and use thereof | NIPPON KAYAKU KK | 2011-08-03 | — | — | CN | disclosed |
| EP-2085379-A1 | Arylsulfonamido-substituted hydroxamic acid derivatives | Novartis AG (CH) | 2009-08-05 | — | — | EP | disclosed |
| US-7521006-B2 | Diimmonium compound and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-21 | — | — | US | disclosed |
| US-20080275127-A1 | Arylsulfonamido-substituted hydroxamic acid derivatives | BREITENSTEIN WERNER | 2008-11-06 | — | — | US | disclosed |
| CN-100430374-C | Diimonium salt compound and use thereof | NIPPON KAYAKU KK (JP) | 2008-11-05 | — | — | CN | disclosed |
| US-20080067478-A1 | Quaternary salt of N,N,N',N'-tetrakis(p-aminophenyl)phenylene diimmonium compound; stability; heat and light resistance; near-infrared aborbing filters, optical recording media and filters, plasma display panels | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-03-20 | — | — | US | disclosed |
| CN-101010290-A | Diimmonium compound and use thereof | NIPPON KAYAKU KK (JP) | 2007-08-01 | — | — | CN | disclosed |
| EP-1787978-A1 | DIIMMONIUM COMPOUND AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2007-05-23 | — | — | EP | disclosed |
| CN-1878747-A | Diimonium salt compound and use thereof | NIPPON KAYAKU KK (JP) | 2006-12-13 | — | — | CN | disclosed |
| US-7138432-B1 | Arylsulfonamido-substituted hydroxamic acid derivatives | NOVARTIS AG (CH) | 2006-11-21 | — | — | US | disclosed |
| EP-1683784-A1 | DIIMONIUM SALT COMPOUND AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-07-26 | — | — | EP | disclosed |
| CN-1215055-C | Arylsulfonylamino-substituted hydroxamic acid derivatives | NOVARTIS AG (CH) | 2005-08-17 | — | — | CN | disclosed |
| US-20050148786-A1 | Diimmonium compound and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA | 2005-07-07 | — | — | US | disclosed |
| CN-1368958-A | Arylsulfonamido-substituted hydroxamic acid derivatives | NOVARTIS AG (CH) | 2002-09-11 | — | — | CN | disclosed |
| EP-1202961-A1 | ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES | Novartis AG (CH) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001010827-A1 | ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES | NOVARTIS AG (CH) | 2001-02-15 | — | — | WO | disclosed |